One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

29 December 2017, 10:19

Teva Launches Generic Reyataz

Teva Launches Generic Reyataz - picture 1

Teva announced the launch of Atazanavir Sulfate Capsules, the generic version of Bristol-Myers Squibb's Reyataz, MPR reports.

Reyataz is indicated for the treatment of HIV-1 infection, in combination with other antiretroviral agents. It is an HIV-1 protease inhibitor that works by selectively inhibiting the virus-specific process of viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions.

Atazanavir Sulfate are available as 150mg and 200mg strength capsules in 60-count bottles and 300mg strength capsules in 30-count bottles.

Author: Narek Karamyan

Share on social media